SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+16.97%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$1.2B
AUM Growth
+$1.2B
(+6%)
Cap. Flow
-$60.2M
Cap. Flow
% of AUM
-5%
Top 10 Holdings %
Top 10 Hldgs %
37.95%
Holding
109
New
16
Increased
24
Reduced
36
Closed
22
Top Buys
| 1 |
Grifois
GRFS
|
$40.2M |
| 2 |
Sanofi
SNY
|
$31.7M |
| 3 |
QuidelOrtho
QDEL
|
$31.3M |
| 4 |
Eli Lilly
LLY
|
$17.1M |
| 5 |
Krystal Biotech
KRYS
|
$16.6M |
Top Sells
| 1 |
TG Therapeutics
TGTX
|
$26M |
| 2 |
Nurix Therapeutics
NRIX
|
$22.2M |
| 3 |
Penumbra
PEN
|
$22.2M |
| 4 |
Vaxcyte
PCVX
|
$18.1M |
| 5 |
Humana
HUM
|
$16.6M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Bausch + Lomb
BLCO
$5.18B
| $6.02M | 0.47% |
+312,000
| New | +$6.02M |
|
|
THTX
52
Theratechnologies
THTX
$149M
| $5.95M | 0.46% |
4,801,376
| – | – |
|
53
Erasca
ERAS
$445M
| $5.9M | 0.46% |
2,162,162
| – | – |
|
54
Applied Therapeutics
APLT
$71M
| $5.79M | 0.45% |
680,784
-588,930
| -46% | -$5.01M |
|
55
Adaptive Biotechnologies
ADPT
$2.01B
| $5.7M | 0.44% |
1,112,749
-607,251
| -35% | -$3.11M |
|
56
Arvinas
ARVN
$568M
| $5.64M | 0.44% |
+228,800
| New | +$5.64M |
|
57
Alector
ALEC
$238M
| $5.63M | 0.44% |
1,207,371
-1,031,635
| -46% | -$4.81M |
|
58
enGene Holdings
ENGN
$236M
| $5.28M | 0.41% |
800,000
| – | – |
|
59
Y-mAbs Therapeutics
YMAB
$388M
| $5.26M | 0.41% |
399,982
-248,000
| -38% | -$3.26M |
|
60
Treace Medical Concepts
TMCI
$464M
| $5.15M | 0.4% |
887,941
-1,477,707
| -62% | -$8.57M |
|
|
SLN
61
Silence Therapeutics
SLN
$227M
| $4.73M | 0.37% |
+260,000
| New | +$4.73M |
|
62
BioAtla
BCAB
$26.7M
| $4.43M | 0.34% |
2,517,478
-1,383,836
| -35% | -$2.44M |
|
63
Dyne Therapeutics
DYN
$1.92B
| $4.22M | 0.33% |
117,500
-83,500
| -42% | -$3M |
|
64
Insulet
PODD
$23.9B
| $3.9M | 0.3% |
16,750
-2,050
| -11% | -$477K |
|
|
NARI
65
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $3.87M | 0.3% |
93,878
-314,495
| -77% | -$13M |
|
66
Natera
NTRA
$23.1B
| $3.8M | 0.29% |
29,900
+26,300
| +731% | +$3.34M |
|
67
InspireMD
NSPR
$102M
| $3.69M | 0.29% |
1,378,128
| – | – |
|
|
MREO
68
Mereo BioPharma
MREO
$272M
| $3.48M | 0.27% |
846,953
-400,000
| -32% | -$1.64M |
|
69
CalciMedica
CALC
$37.7M
| $3.47M | 0.27% |
783,904
| – | – |
|
70
AbbVie
ABBV
$372B
| $3.11M | 0.24% |
+15,750
| New | +$3.11M |
|
|
71
Vaxcyte
PCVX
$4B
| $3.09M | 0.24% |
27,050
-158,200
| -85% | -$18.1M |
|
72
Tango Therapeutics
TNGX
$747M
| $2.64M | 0.2% |
343,152
-706,743
| -67% | -$5.44M |
|
73
Establishment Labs
ESTA
$1.2B
| $2.57M | 0.2% |
59,400
+44,400
| +296% | +$1.92M |
|
74
MDxHealth
MDXH
$176M
| $2.3M | 0.18% |
+1,105,000
| New | +$2.3M |
|
75
Insmed
INSM
$28.8B
| $2.21M | 0.17% |
30,272
-72,200
| -70% | -$5.27M |
|